CeriBell, Inc. Loss Contingency, Receivable, Current
CeriBell, Inc. (CBLL) had Loss Contingency, Receivable, Current of $1.00 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Notes › Commitment and Contingencies › Loss Contingency › Loss Contingency, Related Receivable
us-gaap:LossContingencyReceivableCurrent · last filed 2026-08-10
- 2026-06-30: Loss Contingency, Receivable, Current $1.00M.
| Period end | Loss Contingency, Receivable, Current |
|---|---|
| 2026-06-30 | $1.00M 10-Q · filed 2026-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |